Astrocytes: The missing link in neurologic disease?

Seminars in Pediatric Neurology

Volumn 20, Issue 4, 2013, Pages 236-241

  John Lin, Chia Ching ^a   Deneen, Benjamin ^a,b  

^a CENTER FOR CELL AND GENE THERAPY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMMONIA; AMYLOID BETA PROTEIN; AQUAPORIN; CALCIUM ION; CELL PROTEIN; COPPER ZINC SUPEROXIDE DISMUTASE; EXCITATORY AMINO ACID TRANSPORTER; EXCITATORY AMINO ACID TRANSPORTER 2; FRAGILE X MENTAL RETARDATION PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMIC ACID; GLUTATHIONE PEROXIDASE; MENKES PROTEIN; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID; POTASSIUM ION; PROTEIN FMRP; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

ADRENOLEUKODYSTROPHY; ALEXANDER DISEASE; ALZHEIMER DISEASE; AMINO ACID SYNTHESIS; AMINO ACID TRANSPORT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; ASTROCYTE; AUTISM; AUTOSOMAL DOMINANT DISORDER; BRAIN DEVELOPMENT; BRAIN EDEMA; BRAIN ISCHEMIA; CAG REPEAT; CALCIUM CELL LEVEL; CANAVAN DISEASE; CELL DEATH; CELL FUNCTION; CELL INTERACTION; CELL LOSS; CELL SURVIVAL; CELL TRANSPORT; CELLULAR SECRETION; CENTRAL NERVOUS SYSTEM FUNCTION; CEREBRAL PALSY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DOPAMINERGIC NERVE CELL; EPILEPSY; EXCITOTOXICITY; FRAGILE X SYNDROME; GENE; GENE EXPRESSION; HTT GENE; HUMAN; HUNTINGTON CHOREA; HYPERAMMONEMIA; LEUKODYSTROPHY; LEWY BODY; MECP2 GENE; MENKES SYNDROME; METABOLIC DISORDER; MISSENSE MUTATION; MULTIPLE SCLEROSIS; NERVE CELL DEGENERATION; NEUROFIBRILLARY TANGLE; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; OLIGODENDROCYTE PRECUSOR CELL; OLIGODENDROGLIA; ONSET AGE; PARKINSON DISEASE; PATHOPHYSIOLOGY; POTASSIUM CELL LEVEL; PREMATURITY; PROTEIN EXPRESSION; PROTEIN METABOLISM; RELAPSE; REMYELINIZATION; RETT SYNDROME; RISK FACTOR; UREA CYCLE DISORDER; WHITE MATTER DISORDER; X CHROMOSOME LINKED DISORDER;

ASTROCYTES; HUMANS; NERVOUS SYSTEM DISEASES;

EID: 84890814448     PISSN: 10719091     EISSN: 15580776     Source Type: Journal    
DOI: 10.1016/j.spen.2013.10.004     Document Type: Article

References (80)

1. Singh J., Khan M., Singh I. Silencing of Abcd1 and Abcd2 genes sensitizes astrocytes for inflammation: Implication for X-adrenoleukodystrophy. J Lipid Res 2009, 50(1):135-147. [Epub 2008/08/30].
2. Singh I., Pujol A. Pathomechanisms underlying X-adrenoleukodystrophy: A three-hit hypothesis. Brain Pathol 2010, 20(4):838-844. [Epub 2010/07/16].
3. Baslow M.H., Guilfoyle D.N. Are astrocytes the missing link between lack of brain aspartoacylase activity and the spongiform leukodystrophy in Canavan disease?. Neurochem Res 2009, 34(9):1523-1534. [Epub 2009/03/26].
4. Franklin R.J., Crang A.J., Blakemore W.F. Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J Neurocytol 1991, 20(5):420-430. [Epub 1991/05/01].
5. Lachapelle F., Bachelin C., Moissonnier P., et al. Failure of remyelination in the nonhuman primate optic nerve. Brain Pathol 2005, 15(3):198-207. [Epub 2005/10/04].
6. Talbott J.F., Loy D.N., Liu Y., et al. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes. Exp Neurol 2005, 192(1):11-24. [Epub 2005/02/09].
7. Moore C.S., Abdullah S.L., Brown A., et al. How factors secreted from astrocytes impact myelin repair. J Neurosci Res 2011, 89(1):13-21. [Epub 2010/09/22].
8. Williams A., Piaton G., Lubetzki C. Astrocytes-Friends or foes in multiple sclerosis?. Glia 2007, 55(13):1300-1312. [Epub 2007/07/13].
9. Brenner M., Johnson A.B., Boespflug-Tanguy O., et al. Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet 2001, 27(1):117-120. [Epub 2001/01/04].
10. Jacob J., Robertson N.J., Hilton D.A. The clinicopathological spectrum of Rosenthal fibre encephalopathy and Alexander's disease: A case report and review of the literature. J Neurol Neurosurg Psychiatry 2003, 74(6):807-810. [Epub 2003/05/20].
11. Johnson A.B. Alexander disease: A review and the gene. Int J Dev Neurosci 2002, 20(3-5):391-394. [Epub 2002/08/15].
12. Sawaishi Y. Review of Alexander disease: Beyond the classical concept of leukodystrophy. Brain Dev 2009, 31(7):493-498. [Epub 2009/04/24].
13. Johnson A.B., Brenner M. Alexander's disease: Clinical, pathologic, and genetic features. J Child Neurol 2003, 18(9):625-632. [Epub 2003/10/24].
14. Messing A., Goldman J.E., Johnson A.B., et al. Alexander disease: New insights from genetics. J Neuropathol Exp Neurol 2001, 60(6):563-573. [Epub 2001/06/12].
15. Messing A., Head M.W., Galles K., et al. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Pathol 1998, 152(2):391-398. [Epub 1998/02/18].
16. Nelson K.B. Can we prevent cerebral palsy?. N Engl J Med 2003, 349(18):1765-1769. [Epub 2003/10/31].
17. Hemminki K., Li X., Sundquist K., et al. High familial risks for cerebral palsy implicate partial heritable aetiology. Paediatr Perinat Epidemiol 2007, 21(3):235-241. [Epub 2007/04/19].
18. Krigger K.W. Cerebral palsy: An overview. Am Fam Physician 2006, 73(1):91-100. [Epub 2006/01/19].
19. Fern R: Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes in situ. J Neurosci. 18:7232-7243, 1998 [Epub 1998/09/16].
20. Sen E., Levison S.W. Astrocytes and developmental white matter disorders. Ment Retard Dev Disabil Res Rev 2006, 12(2):97-104. [Epub 2006/06/30].
21. Anderson C.M., Swanson R.A. Astrocyte glutamate transport: Review of properties, regulation, and physiological functions. Glia 2000, 32(1):1-14. [Epub 2000/09/07].
22. Sonnewald U., Westergaard N., Schousboe A. Glutamate transport and metabolism in astrocytes. Glia 1997, 21(1):56-63. [Epub 1997/09/23].
23. Vargas-Lowy D., Chitnis T. Pathogenesis of pediatric multiple sclerosis. J Child Neurol 2012, 27(11):1394-1407. [Epub 2012/09/07].
24. Gorman M.P., Healy B.C., Polgar-Turcsanyi M., et al. Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis. Arch Neurol 2009, 66(1):54-59. [Epub 2009/01/14].
25. Bigi S., Banwell B. Pediatric multiple sclerosis. J Child Neurol 2012, 27(11):1378-1383. [Epub 2012/08/24].
26. Nair A., Frederick T.J., Miller S.D. Astrocytes in multiple sclerosis: A product of their environment. Cell Mol Life Sci 2008, 65(17):2702-2720. [Epub 2008/06/03].
27. Van Der Voorn P., Tekstra J., Beelen R.H., et al. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am J Pathol 1999, 154(1):45-51. [Epub 1999/01/23].
28. Minagar A., Shapshak P., Fujimura R., et al. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia Alzheimer disease, and multiple sclerosis. J Neurol Sci 2002, 202(1-2):13-23. [Epub 2002/09/11].
29. Miljkovic D., Timotijevic G., Mostarica Stojkovic M. Astrocytes in the tempest of multiple sclerosis. FEBS Lett 2011, 585(23):3781-3788. [Epub 2011/03/30].
30. 2012 Alzheimer's disease facts and figures. Alzheimers Dement 2012, 8(2):131-168.
31. Maragakis N.J., Rothstein J.D. Mechanisms of disease: Astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2006, 2(12):679-689. [Epub 2006/11/23].
32. Selkoe D.J. Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 2001, 81(2):741-766. [Epub 2001/03/29].
33. Nagele R.G., Wegiel J., Venkataraman V., et al. Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol Aging 2004, 25(5):663-674. [Epub 2004/06/03].
34. Teismann P., Schulz J.B. Cellular pathology of Parkinson's disease: Astrocytes, microglia and inflammation. Cell Tissue Res 2004, 318(1):149-161. [Epub 2004/09/01].
35. Cabezas R, Avila MF, Torrente D, et al: Astrocytes Role in Parkinson: A Double-Edged Sword 2013.
36. Bambrick L., Kristian T., Fiskum G. Astrocyte mitochondrial mechanisms of ischemic brain injury and neuroprotection. Neurochem Res 2004, 29(3):601-608. [Epub 2004/03/25].
37. Dringen R. Metabolism and functions of glutathione in brain. Prog Neurobiol 2000, 62(6):649-671. [Epub 2000/07/06].
38. Zheng L., Ishii Y., Tokunaga A., et al. Neuroprotective effects of PDGF against oxidative stress and the signaling pathway involved. J Neurosci Res 2010, 88(6):1273-1284. [Epub 2009/12/10].
39. Andrew S.E., Goldberg Y.P., Kremer B., et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet 1993, 4(4):398-403. [Epub 1993/08/01].
40. Hsiao H.Y., Chen Y.C., Chen H.M., et al. A critical role of astrocyte-mediated nuclear factor-kappaB-dependent inflammation in Huntington's disease. Hum Mol Genet 2013, 22(9):1826-1842. [Epub 2013/02/02].
41. Hsiao H.Y., Chern Y. Targeting glial cells to elucidate the pathogenesis of Huntington's disease. Mol Neurobiol 2010, 41(2-3):248-255. [Epub 2010/01/29].
42. Sugars K.L., Rubinsztein D.C. Transcriptional abnormalities in Huntington disease. Trends Genet 2003, 19(5):233-238. [Epub 2003/04/25].
43. Li S.H., Li X.J. Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet 2004, 20(3):146-154. [Epub 2004/03/24].
44. Lievens J.C., Woodman B., Mahal A., et al. Impaired glutamate uptake in the R6 Huntington's disease transgenic mice. Neurobiol Dis 2001, 8(5):807-821. [Epub 2001/10/11].
45. Shin J.Y., Fang Z.H., Yu Z.X., et al. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 2005, 171(6):1001-1012. [Epub 2005/12/21].
46. Julien J.P. ALS: Astrocytes move in as deadly neighbors. Nat Neurosci 2007, 10(5):535-537. [Epub 2007/04/25].
47. Bristol L.A., Rothstein J.D. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 1996, 39(5):676-679. [Epub 1996/05/01].
48. Rosen D.R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 364(6435):362. [Epub 1993/07/22].
49. Di Giorgio F.P., Carrasco M.A., Siao M.C., et al. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 2007, 10(5):608-614. [Epub 2007/04/17].
50. Nagai M., Re D.B., Nagata T., et al. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 2007, 10(5):615-622. [Epub 2007/04/17].
51. Chahrour M., Zoghbi H.Y. The story of Rett syndrome: From clinic to neurobiology. Neuron 2007, 56(3):422-437. [Epub 2007/11/09].
52. Neul J.L. The relationship of Rett syndrome and MECP2 disorders to autism. Dialogues Clin Neurosci 2012, 14(3):253-262. [Epub 2012/12/12].
53. Amir R.E., Van den Veyver I.B., Wan M., et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999, 23(2):185-188. [Epub 1999/10/03].
54. Ballas N., Lioy D.T., Grunseich C., et al. Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 2009, 12(3):311-317. [Epub 2009/02/24].
55. Zoghbi H.Y. Rett syndrome: What do we know for sure?. Nat Neurosci 2009, 12(3):239-240. [Epub 2009/02/25].
56. Molofsky A.V., Krencik R., Ullian E.M., et al. Astrocytes and disease: A neurodevelopmental perspective. Genes Dev 2012, 26(9):891-907. [Epub 2012/05/03].
57. Lioy D.T., Garg S.K., Monaghan C.E., et al. A role for glia in the progression of Rett's syndrome. Nature 2011, 475(7357):497-500. [Epub 2011/07/01].
58. Beckel-Mitchener A., Greenough W.T. Correlates across the structural, functional, and molecular phenotypes of fragile X syndrome. Ment Retard Dev Disabil Res Rev 2004, 10(1):53. [Epub 2004/03/03].
59. Hagerman P.J. The fragile X prevalence paradox. J Med Genet 2008, 45(8):498-499. [Epub 2008/04/17].
60. Jacobs S., Doering L.C. Astrocytes prevent abnormal neuronal development in the fragile x mouse. J Neurosci 2010, 30(12):4508-4514. [Epub 2010/03/26].
61. Huber K.M., Gallagher S.M., Warren S.T., et al. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A 2002, 99(11):7746-7750. [Epub 2002/05/29].
62. Pacey L.K., Doering L.C. Developmental expression of FMRP in the astrocyte lineage: Implications for fragile X syndrome. Glia 2007, 55(15):1601-1609. [Epub 2007/09/08].
63. Russ S.A., Larson K., Halfon N. A national profile of childhood epilepsy and seizure disorder. Pediatrics 2012, 129(2):256-264. [Epub 2012/01/25].
64. Pandolfo M. Pediatric epilepsy genetics. Curr Opin Neurol 2013, 26(2):137-145. [Epub 2013/03/02].
65. Kubova H., Lukasiuk K., Pitkanen A. New insight on the mechanisms of epileptogenesis in the developing brain. Adv Tech Stand Neurosurg 2012, 39:3-44. [Epub 2012/12/20].
66. Devinsky O., Vezzani A., Najjar S., et al. Glia and epilepsy: Excitability and inflammation. Trends Neurosci 2013, 36(3):174-184. [Epub 2013/01/10].
67. Holthoff K., Witte O.W. Directed spatial potassium redistribution in rat neocortex. Glia 2000, 29(3):288-292. [Epub 2000/01/22].
68. Kuffler S.W., Nicholls J.G. The physiology of neuroglial cells. Ergeb Physiol Biol Chem Exp Pharmakol 1966, 57:1-90. [Epub 1966/01/01].
69. Takata N., Hirase H. Cortical layer 1 and layer 2/3 astrocytes exhibit distinct calcium dynamics in vivo. PLoS ONE 2008, 3(6):e2525. [Epub 2008/06/26].
70. Wetherington J., Serrano G., Dingledine R. Astrocytes in the epileptic brain. Neuron 2008, 58(2):168-178. [Epub 2008/04/29].
71. Norenberg M.D., Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979, 161(2):303-310. [Epub 1979/02/02].
72. Parpura V., Verkhratsky A. Astrocytes revisited: Concise historic outlook on glutamate homeostasis and signaling. Croat Med J 2012, 53(6):518-528. [Epub 2013/01/01].
73. Eid T, Tu N, Lee TS, et al. Regulation of astrocyte glutamine synthetase in epilepsy. Neurochem Int [Epub 2013/06/25] pii/S0197018613001708#.
74. Gallagher CL, Rice GM, Hsu D: Metabolic Disorders in Pediatric Neurology. In: Gallagher C (ed): Neurology Board Review Manual: Turner White communication inc, 2005.
75. Kaler S.G. ATP7A-related copper transport diseases-emerging concepts and future trends. Nat Rev Neurol 2011, 7(1):15-29. [Epub 2011/01/12].
76. Tiffany-Castiglioni E., Hong S., Qian Y. Copper handling by astrocytes: Insights into neurodegenerative diseases. Int J Dev Neurosci 2011, 29(8):811-818. [Epub 2011/10/05].
77. Kodama H. Recent developments in Menkes disease. J Inherit Metab Dis 1993, 16(4):791-799. [Epub 1993/01/01].
78. Kodama H., Meguro Y., Abe T., et al. Genetic expression of Menkes disease in cultured astrocytes of the macular mouse. J Inherit Metab Dis 1991, 14(6):896-901. [Epub 1991/01/01].
79. Lichter-Konecki U., Mangin J.M., Gordish-Dressman H., et al. Gene expression profiling of astrocytes from hyperammonemic mice reveals altered pathways for water and potassium homeostasis in vivo. Glia 2008, 56(4):365-377. [Epub 2008/01/11].
80. Sirko S., Behrendt G., Johansson P.A., et al. Reactive glia in the injured brain acquire stem cell properties in response to sonic hedgehog. Cell Stem Cell 2013, 12:426-439.